Find Homoharringtonine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Annual Reports

NA

Finished Drug Prices

NA

30 RELATED EXCIPIENT COMPANIES

61EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Homoharringtonine, Ceflatonin, Myelostat, 26833-87-4, Synribo, Cgx-635
Molecular Formula
C29H39NO9
Molecular Weight
545.6  g/mol
InChI Key
HYFHYPWGAURHIV-JFIAXGOJSA-N
FDA UNII
6FG8041S5B

Homoharringtonine
Semisynthetic derivative of harringtonine that acts as a protein synthesis inhibitor and induces APOPTOSIS in tumor cells. It is used in the treatment of MYELOID LEUKEMIA, CHRONIC.
1 2D Structure

Homoharringtonine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
1-O-[(2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-yl] 4-O-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate
2.1.2 InChI
InChI=1S/C29H39NO9/c1-27(2,33)8-5-10-29(34,16-23(31)36-4)26(32)39-25-22(35-3)15-28-9-6-11-30(28)12-7-18-13-20-21(38-17-37-20)14-19(18)24(25)28/h13-15,24-25,33-34H,5-12,16-17H2,1-4H3/t24-,25-,28+,29-/m1/s1
2.1.3 InChI Key
HYFHYPWGAURHIV-JFIAXGOJSA-N
2.1.4 Canonical SMILES
CC(C)(CCCC(CC(=O)OC)(C(=O)OC1C2C3=CC4=C(C=C3CCN5C2(CCC5)C=C1OC)OCO4)O)O
2.1.5 Isomeric SMILES
CC(C)(CCC[C@@](CC(=O)OC)(C(=O)O[C@H]1[C@H]2C3=CC4=C(C=C3CCN5[C@@]2(CCC5)C=C1OC)OCO4)O)O
2.2 Other Identifiers
2.2.1 UNII
6FG8041S5B
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Ceflatonin

2. Cephalotaxine

3. Homoharringtonine

4. Homoharringtonine (3(r))-isomer

5. Omacetaxine

6. Synribo

2.3.2 Depositor-Supplied Synonyms

1. Homoharringtonine

2. Ceflatonin

3. Myelostat

4. 26833-87-4

5. Synribo

6. Cgx-635

7. Omapro

8. Homoharringtonin

9. (-)-homoharringtonine

10. Nsc-141633

11. C29h39no9

12. Chebi:71019

13. (2'r,3s,4s,5r)-(-)-homoharringtonine

14. Omacetaxine (homoharringtonine)

15. Omacetaxine Mepesuccinate [usan]

16. 6fg8041s5b

17. Nsc 141633

18. 1-o-[(2s,3s,6r)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-yl] 4-o-methyl (2r)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate

19. Cephalotaxine 4-methyl (2r)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate

20. Omacetaxine Mepesuccinate (usan)

21. Tekinex

22. Synribo (tn)

23. Cephalotaxine, 4-methyl (2r)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester)

24. Unii-6fg8041s5b

25. Nsc141633

26. Ncgc00025155-01

27. Omacetaxine Mepesuccinate [usan:inn]

28. Brn 5687925

29. Omacetaxini Mepesuccinas

30. Zj-c

31. Mepesuccinate D'omacetaxine

32. Mepesuccinato De Omacetaxina

33. Cephalotaxine 4-methyl (2r)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester)

34. Mls001424293

35. Chembl46286

36. Homoharringtonine [mi]

37. Cgx-635-14 (formulation)

38. Gtpl7454

39. Schembl12745687

40. Hms3267h22

41. Hms3414n05

42. Hms3678n03

43. Amy33459

44. Homoharringtonine, >=98% (hplc)

45. Bdbm50480293

46. Mfcd05618221

47. Nsc758253

48. S9015

49. Zinc26011099

50. Akos024456585

51. Ccg-269981

52. Db04865

53. Nc00395

54. Nsc-758253

55. Omacetaxine Mepesuccinate [inn]

56. Ncgc00025155-02

57. Ncgc00025155-03

58. Ncgc00025155-04

59. Ncgc00025155-07

60. Omacetaxine Mepesuccinate [mart.]

61. Omacetaxine Mepesuccinate [vandf]

62. Hy-14944

63. Nci60_000917

64. Omacetaxine Mepesuccinate [who-dd]

65. Smr000469230

66. H1775

67. N1504

68. D08956

69. Omacetaxine Mepesuccinate [orange Book]

70. Ab00642561-02

71. Sr-01000597562

72. Q7089373

73. Sr-01000597562-1

74. Brd-k76674262-001-01-7

75. Brd-k76674262-001-02-5

76. Cephalotaxine, 3-[4-methyl (2r)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate]

77. Cephalotaxine, 4-methyl-, 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate (ester)

78. (s)-1-((11bs,12s,14ar)-13-methoxy-2,3,5,6,11b,12-hexahydro-1h-[1,3]dioxolo[4',5':4,5]benzo[1,2-d]cyclopenta[b]pyrrolo[1,2-a]azepin-12-yl) 4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)succinate

79. 1-((1s,3ar,14bs)-2-methoxy-1,5,6,8,9,14b-hexahydro-4h- Cyclopenta(a)(1,3)dioxolo(4,5-h)pyrrolo(2,1-b)(3)benzazepin-1-yl) 4-methyl (2r)-2- Hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate

80. 1-((1s,3ar,14bs)-2-methoxy-1,5,6,8,9,14b-hexahydro-4h-cyclopenta(a)(1,3)dioxolo(4,5-h)pyrrolo(2,1-b)(3)benzazepin-1-yl) 4-methyl (2r)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate

81. Homoharringtonine; Cephalotaxine; [3(r)]-4-methyl 2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate

2.4 Create Date
2005-03-26
3 Chemical and Physical Properties
Molecular Weight 545.6 g/mol
Molecular Formula C29H39NO9
XLogP30.8
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count10
Rotatable Bond Count11
Exact Mass545.26248182 g/mol
Monoisotopic Mass545.26248182 g/mol
Topological Polar Surface Area124 Ų
Heavy Atom Count39
Formal Charge0
Complexity968
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameSynribo
PubMed HealthOmacetaxine (Injection)
Drug ClassesAntineoplastic Agent
Drug LabelSYNRIBO contains the active ingredient omacetaxine mepesuccinate, a cephalotaxine ester. It is a protein synthesis inhibitor. Omacetaxine mepesuccinate is prepared by a semi-synthetic process from cephalotaxine, an extract from the leaves of Cephalot...
Active IngredientOmacetaxine mepesuccinate
Dosage FormPowder
RouteSubcutaneous
Strength3.5mg/vial
Market StatusPrescription
CompanyIvax Intl

2 of 2  
Drug NameSynribo
PubMed HealthOmacetaxine (Injection)
Drug ClassesAntineoplastic Agent
Drug LabelSYNRIBO contains the active ingredient omacetaxine mepesuccinate, a cephalotaxine ester. It is a protein synthesis inhibitor. Omacetaxine mepesuccinate is prepared by a semi-synthetic process from cephalotaxine, an extract from the leaves of Cephalot...
Active IngredientOmacetaxine mepesuccinate
Dosage FormPowder
RouteSubcutaneous
Strength3.5mg/vial
Market StatusPrescription
CompanyIvax Intl

4.2 Drug Indication

Used in patients who are intolerant and/or resistant to two or more tyrosine kinase inhibitors used to treat accelerated or chronic phase CML.


FDA Label


Philadelphia chromosome positive chronic myeloid leukaemia in patients who have the T315I Bcr-Abl kinase domain mutation and who are resistant to prior imatinib therapy.


5 Pharmacology and Biochemistry
5.1 Pharmacology

The pharmacodynamics of homoharringtonine is not fully understood. It is known that homoharringtonine is involved with protein synthesis inhibition and this leads to its antineoplastic activity.


5.2 MeSH Pharmacological Classification

Antineoplastic Agents, Phytogenic

Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)


Protein Synthesis Inhibitors

Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)


5.3 ATC Code

L - Antineoplastic and immunomodulating agents

L01 - Antineoplastic agents

L01X - Other antineoplastic agents

L01XX - Other antineoplastic agents

L01XX40 - Omacetaxine mepesuccinate


5.4 Absorption, Distribution and Excretion

Absorption

Homoharringtonine absorption was not quantified, but maximum concentration is reached after about 30 mins.


Route of Elimination

The main route of elimination for homoharringtonine is still unknown, but renal elimination is less than 15%.


Volume of Distribution

Homoharringtonine has a steady state Vd of 141 93.4 L.


Clearance

Clearance for homoharringtonine was not quantified.


5.5 Metabolism/Metabolites

Homoharringtonine has undergoes little hepatic metabolism and is mostly metabolized to 4-DMHHT by plasma esterase hydrolysis.


5.6 Biological Half-Life

Homoharringtonine has a half life of about 6 hours after subcutaneous administration.


5.7 Mechanism of Action

Homoharringtonine inhibits protein synthesis by not directly binding to Bcr-Abl. It binds to the A-site cleft in the large ribosomal subunit, which affects chain elongation and prevents protein synthesis.


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Taste Masking

read-more
read-more

Direct Compression

read-more
read-more

Co-Processed Excipients

read-more
read-more

Parenteral

read-more
read-more

Granulation

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

API Stability Enhancers

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty